AKT1 and neoplasm: Further pathway enrichment analysis revealed that SLC5A3 + tumor cells exhibit higher activity in pathways related to cholesterol metabolism, the PI3K-Akt signaling pathway, and the TGF-β signaling pathway (Fig. 9E).